Multi-faceted strategies to advance health equity in colorectal cancer screening in primary care setting: quality improvement project.

Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Colorectal Neoplasms*/diagnosis ; Quality Improvement* ; Primary Health Care* ; Early Detection of Cancer*/methods ; Health Equity*; Humans ; Middle Aged ; Aged ; Female ; Male ; Health Literacy ; Colonoscopy/statistics & numerical data

Background: The aim of this quality improvement (QI) project was to increase Colorectal Cancer (CRC) screening in patients ages 50-75 years from a baseline of 27-40% within 12 months in a primary care clinic in limited resource communities.
Methods: The multidisciplinary QI-team applied the Plan-Do-Study-Act method and developed stakeholder analysis, an Ishikawa fish bone diagram, a process flow map, and a driver diagram. Major barriers to suboptimal CRC screening included limited health literacy, language preferences, absence of stool test options, and knowledge gaps among patients and providers. The outcome measure was CRC screening rates, while stool test and colonoscopy completion rates served as process measures. Major interventions included the use of a patient-navigator, leveraging digital health technology to create a novel CRC screening data dashboard, educating patients and providers, patient centered-shared decision making, and creating messages and educational videos in patient's preferred languages. We used monthly run charts and statistical process control charts (SPC) for data analysis.
Results: We observed a sustainable, steady increase in CRC screening rates from baseline rates of 27.0-40.0% (n = 1304/3271) during the study period and 45.6% (n = 1493/3,271) six months post-study, with median rates of 34.0% in the run chart and mean rates of 43.0% in the SPC chart. Furthermore, we observed an increase in colonoscopy completion rates during the study and six months post-study to 65.0% (n = 411/631) and 72.9% (n = 461/631) respectively, from a baseline rate of 25.0%, with a median of 63.0% in the monthly run chart.
Conclusion: The increase in CRC screening rates highlights the effectiveness of addressing barriers such as health literacy, language preferences, and knowledge gaps. This underscores the value of a multifaceted approach and the role of a patient navigator in enhancing preventive, patient-centered care. This project focused on population health and addressing social determinants of health to overcome disparities and improve CRC screening in a primary care setting. Continued emphasis on these strategies is likely to further advance colorectal cancer screening efforts.
Competing Interests: Declarations Ethics approval and consent to participate This study was reviewed by the University at Buffalo human subject institutional review board and was classified as exempt from human subjects. The University at Buffalo human subject institutional review board determined that the proposed activity is not research involving human subjects (Exempt). It was written and planned as a Quality Improvement project. STUDY00005976. Informed consent was waived by University at Buffalo human subject institutional review board. Survey was developed for this study. Consent for publication The University at Buffalo human subject institutional review board determined that the proposed activity is not research involving human subjects. Informed consent was waived by the University at Buffalo human subject institutional review board. No consent for publication necessary. Competing interests The authors declare no competing interests.
(© 2024. The Author(s).)

World J Clin Cases. 2021 Jul 26;9(21):5850-5859. (PMID: 34368304)
Am J Public Health. 2010 Oct;100(10):1912-6. (PMID: 20724684)
Hosp Pharm. 2023 Jun;58(3):225-226. (PMID: 37216076)
J Health Commun. 2013;18 Suppl 1:242-55. (PMID: 24093359)
J Natl Cancer Inst. 2021 Feb 1;113(2):154-161. (PMID: 32761199)
Qual Saf Health Care. 2008 Apr;17(2):137-45. (PMID: 18385409)
N Engl J Med. 2014 Apr 3;370(14):1287-97. (PMID: 24645800)
JAMA. 2021 May 18;325(19):1965-1977. (PMID: 34003218)
BMJ Qual Saf. 2011 Jan;20(1):46-51. (PMID: 21228075)
Am J Prev Med. 2014 Mar;46(3):228-36. (PMID: 24512861)
BMJ Open Qual. 2018 Oct 25;7(4):e000400. (PMID: 30397662)
J Fam Med. 2017;4(3):. (PMID: 29399669)
Am Fam Physician. 2022 Feb 1;105(2):198-200. (PMID: 35166507)
JAMA Netw Open. 2020 Mar 2;3(3):e200618. (PMID: 32150271)
JMIR Res Protoc. 2022 Mar 2;11(3):e34894. (PMID: 35234650)
J Am Assoc Nurse Pract. 2023 Jul 01;35(7):415-424. (PMID: 36745041)
J Gen Intern Med. 2015 Jul;30(7):942-9. (PMID: 25678378)
J Natl Cancer Inst. 2014 Apr;106(4):dju032. (PMID: 24681602)
Gastroenterology. 2020 Jan;158(2):354-367. (PMID: 31682851)
CA Cancer J Clin. 2023 Nov-Dec;73(6):565-589. (PMID: 37358040)
BMJ Open Qual. 2023 Oct;12(4):. (PMID: 37797960)
CA Cancer J Clin. 2021 Jan;71(1):7-33. (PMID: 33433946)
J Gen Intern Med. 2007 Aug;22(8):1195-205. (PMID: 17534688)
Br J Cancer. 2023 Apr;128(6):946-957. (PMID: 36476659)
Prev Chronic Dis. 2018 Aug 09;15:E100. (PMID: 30095405)
Glob J Qual Saf Healthc. 2022 Jun 2;5(2):44-46. (PMID: 37260837)
Lancet Digit Health. 2023 Nov;5(11):e831-e839. (PMID: 37890905)
CA Cancer J Clin. 2023 Sep-Oct;73(5):461-479. (PMID: 37329257)
Iran Red Crescent Med J. 2014 Jan;16(1):e12454. (PMID: 24719703)
Front Public Health. 2024 Jun 19;12:1414361. (PMID: 38962767)
J Pediatric Infect Dis Soc. 2018 May 15;7(2):100-103. (PMID: 29040644)
Oncologist. 2021 Oct;26(10):e1730-e1741. (PMID: 34288237)
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):614-621. (PMID: 27999144)

T34HP42144-0200 Health Resources and Services Administration (HRSA) Primary Care and Enhancement Community Prevention and Maternal Health award

Keywords: Colorectal cancer screening; Dashboard; Primary care

Date Created: 20241118 Date Completed: 20241119 Latest Revision: 20241121

20241121

PMC11572305

10.1186/s12913-024-11928-7

39558206